Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-26-050803
Filing Date
2026-07-30
Accepted
2026-07-30 07:34:09
Documents
122
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 6-K sny-20260630.htm   iXBRL 6-K 389278
2 EX-99.1 sny-20260630_d2.htm   iXBRL EX-99.1 1627617
3 EX-99.2 exhibit992-2026halfyearman.htm EX-99.2 724165
10 a2026coverhalf-yearfinanci.jpg GRAPHIC 119354
11 a2026coverhalf-yearfinancia.jpg GRAPHIC 162853
  Complete submission text file 0001628280-26-050803.txt   14016187

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sny-20260630.xsd EX-101.SCH 164387
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sny-20260630_cal.xml EX-101.CAL 161377
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sny-20260630_def.xml EX-101.DEF 541906
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sny-20260630_lab.xml EX-101.LAB 1096154
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sny-20260630_pre.xml EX-101.PRE 767311
128 EXTRACTED XBRL INSTANCE DOCUMENT sny-20260630_htm.xml XML 2599227
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 261220209
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)